Does Complexity and Racialization Limit PSA Screening?

The article focuses on the racial disparities in prostate cancer care, particularly in screening practices, which vary widely among medical organizations and contribute to confusion and reduced screening rates. Topics include the impact of guideline variations on screening decisions, the persistent mortality disparities despite PSA screening availability, and the complexity introduced by differing recommendations for initiating screening.